Burzynski Research Institute, Inc. (BZYR)

OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0040 (-11.76%)
Feb 11, 2026, 9:30 AM EST
Market Cap3.94M -48.3%
Revenue (ttm)n/a
Net Income-1.29M
EPS-0.01
Shares Out131.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,000
Average Volume21,098
Open0.0300
Previous Close0.0340
Day's Range0.0300 - 0.0300
52-Week Range0.0170 - 0.0586
Beta0.45
RSI50.18
Earnings DateMay 28, 2026

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1977
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol BZYR
Full Company Profile

Financial Performance

Financial Statements